
WHO WE ARE
Carocell Bio’s leadership team has extensive global experience in drug development and is committed to developing new medicines for patients with inflammatory diseases
Carocell Bio executive team

Dr Mike Davies MD, FRCRS, FRSPSG
CEO & Founder
- Over 25 years’ global executive leadership experience in drug development in pharma (Pfizer, AstraZeneca, Shire) and biotech
- Expertise in early-stage development and taking medicines from ideation to the market
- Founder of Carocell Bio
John Nicholson
Chairman
- International experience in the pharmaceutical and chemical industries
- Funded and managed Analytical Services companies
- Advisory Board member of the UK North West Business Fund
- Previous Chairman Gentronix


Ann R. Mackey
Chief Financial Officer
- Successful track record of leadership, launching operational initiatives, attracting talented managers, and developing effective teams.
- Experienced with capital markets, corporate structuring, acquisitions, and venture capital.
Carocell Bio Advisory Team
Professor Fadi Issa
Consultant Burns and Plastic Surgeon
Buckinghamshire Healthcare NHS Trust Hospital & Health Care, Aylesbury , Buckinghamshire
Professor John Mclaughlin
Scientific Advisor, IBD
Professor of Gastroenterology and Nutrition, Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, UK
Professor Donald YM Leung
Scientific Advisor, AD
Professor and Head of the Division of Pediatric Allergy and Immunology, Department of Pediatrics at University of Colorado Denver School of Medicine, Denver, United States
Carocell Bio Support team
Jane Davies, RN, RM
Project Assistant
Simon Bradbury
Patent Advisor
Partner at Appleyard Lees, Manchester
Ruth James, AAC
Financial Advisor
Partner at Nolan James Chartered Accountants, Poynton
Dave Black
Marketing Consultant
Partner at Onside Creative
Sue Streatfield
Legal Advisor
Partner at Clarion Solicitors, Leeds